BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bouquet J, Tabor DE, Silver JS, Nair V, Tovchigrechko A, Griffin MP, Esser MT, Sellman BR, Jin H. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort. Respir Res 2020;21:77. [PMID: 32228581 DOI: 10.1186/s12931-020-01340-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu S, Zhang H, Wan L, Xue M, Zhang Y, Gao X. The association between the respiratory tract microbiome and clinical outcomes in patients with COPD. Microbiological Research 2023;266:127244. [DOI: 10.1016/j.micres.2022.127244] [Reference Citation Analysis]
2 Keir HR, Chalmers JD. Rebuttal From Dr Keir and Prof Chalmers. Chest 2022;162:977-978. [DOI: 10.1016/j.chest.2022.07.012] [Reference Citation Analysis]
3 Millares L, Monso E. The Microbiome in COPD: Emerging Potential for Microbiome-Targeted Interventions. Int J Chron Obstruct Pulmon Dis 2022;17:1835-45. [PMID: 35983167 DOI: 10.2147/COPD.S371958] [Reference Citation Analysis]
4 Joean O, Welte T. Vaccination and modern management of chronic obstructive pulmonary disease - a narrative review. Expert Rev Respir Med 2022;:1-10. [PMID: 35713962 DOI: 10.1080/17476348.2022.2092099] [Reference Citation Analysis]
5 Rao CM, Sarbhai K, Subhankar S, Mohapatra A, Singh N, Panda PS, Patro S, Pati S. Pathogens Isolated and Their Association With the Long-Term Outcome in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Cureus 2022. [DOI: 10.7759/cureus.26174] [Reference Citation Analysis]
6 Russo C, Colaianni V, Ielo G, Valle MS, Spicuzza L, Malaguarnera L. Impact of Lung Microbiota on COPD. Biomedicines 2022;10:1337. [DOI: 10.3390/biomedicines10061337] [Reference Citation Analysis]
7 Love ME, Proud D. Respiratory Viral and Bacterial Exacerbations of COPD—The Role of the Airway Epithelium. Cells 2022;11:1416. [DOI: 10.3390/cells11091416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Campbell CD, Barnett C, Sulaiman I. A clinicians’ review of the respiratory microbiome. Breathe 2022;18:210161. [DOI: 10.1183/20734735.0161-2021] [Reference Citation Analysis]
9 Martinez-garcía MA, Rigau D, Barrecheguren M, García-ortega A, Nuñez A, Oscullo Yepez G, Miravitlles M. Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis. COPD 2022;Volume 17:371-82. [DOI: 10.2147/copd.s346294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Melo-dias S, Valente C, Andrade L, Marques A, Sousa A. Saliva as a non-invasive specimen for COPD assessment. Respir Res 2022;23. [DOI: 10.1186/s12931-022-01935-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Ke L, Chen L, Yaling Y, Can G, Jun L, Chuan Z. Investigation on the Pathological Mechanism of Frequent Exacerbators With Chronic Obstructive Pulmonary Disease Based on the Characteristics of Respiratory Flora. Front Med 2022;8:816802. [DOI: 10.3389/fmed.2021.816802] [Reference Citation Analysis]
12 Serigstad S, Markussen D, Grewal HMS, Ebbesen M, Kommedal Ø, Heggelund L, van Werkhoven CH, Faurholt-Jepsen D, Clark TW, Ritz C, Ulvestad E, Bjørneklett R, Knoop ST; CAPNOR Study Group. Rapid syndromic PCR testing in patients with respiratory tract infections reduces time to results and improves microbial yield. Sci Rep 2022;12:326. [PMID: 35013351 DOI: 10.1038/s41598-021-03741-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
13 Armitage MN, Spittle DA, Turner AM. A Systematic Review and Meta-Analysis of the Prevalence and Impact of Pulmonary Bacterial Colonisation in Stable State Chronic Obstructive Pulmonary Disease (COPD). Biomedicines 2022;10:81. [DOI: 10.3390/biomedicines10010081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Ruan R, Deng X, Dong X, Wang Q, Lv X, Si C. Microbiota Emergencies in the Diagnosis of Lung Diseases: A Meta-Analysis. Front Cell Infect Microbiol 2021;11:709634. [PMID: 34621687 DOI: 10.3389/fcimb.2021.709634] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Morrow JD, Castaldi PJ, Chase RP, Yun JH, Lee S, Liu YY, Hersh CP. Peripheral blood microbial signatures in current and former smokers. Sci Rep 2021;11:19875. [PMID: 34615932 DOI: 10.1038/s41598-021-99238-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Goolam Mahomed T, Peters RPH, Allam M, Ismail A, Mtshali S, Goolam Mahomed A, Ueckermann V, Kock MM, Ehlers MM. Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa. Sci Rep 2021;11:19758. [PMID: 34611216 DOI: 10.1038/s41598-021-99127-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Rodrigues SO, Cunha CMCD, Soares GMV, Silva PL, Silva AR, Gonçalves-de-Albuquerque CF. Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease. Pharmaceuticals (Basel) 2021;14:979. [PMID: 34681202 DOI: 10.3390/ph14100979] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
18 Whiteside SA, McGinniss JE, Collman RG. The lung microbiome: progress and promise. J Clin Invest 2021;131:150473. [PMID: 34338230 DOI: 10.1172/JCI150473] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
19 Kotlyarov S, Kotlyarova A. Molecular Mechanisms of Lipid Metabolism Disorders in Infectious Exacerbations of Chronic Obstructive Pulmonary Disease. Int J Mol Sci 2021;22:7634. [PMID: 34299266 DOI: 10.3390/ijms22147634] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
20 Li B, Mao Q, Zhou D, Luo M, Gan R, Li H, Huang S, Saimaiti A, Shang A, Li H. Effects of Tea against Alcoholic Fatty Liver Disease by Modulating Gut Microbiota in Chronic Alcohol-Exposed Mice. Foods 2021;10:1232. [PMID: 34071491 DOI: 10.3390/foods10061232] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
21 Yin T, Jeong JH, Hardcastle TF, Biswas K, Douglas RG. A scoping review of longitudinal airway microbiota studies. Expert Rev Respir Med 2021;15:1187-95. [PMID: 33908842 DOI: 10.1080/17476348.2021.1924061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Cyprian F, Sohail MU, Abdelhafez I, Salman S, Attique Z, Kamareddine L, Al-Asmakh M. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections. Int J Infect Dis 2021;105:540-50. [PMID: 33610778 DOI: 10.1016/j.ijid.2021.02.071] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
23 Acevedo N, Escamilla-gil JM, Espinoza H, Regino R, Ramírez J, de Arco LF, Dennis R, Torres-duque C, Caraballo L. Patients with Asthma and Chronic Obstructive Pulmonary Disease (COPD) have increased levels of plasma inflammatory mediators upregulated in severe COVID-19.. [DOI: 10.1101/2021.01.23.21250370] [Reference Citation Analysis]
24 Signes-Costa J, Núñez-Gil IJ, Soriano JB, Arroyo-Espliguero R, Eid CM, Romero R, Uribarri A, Fernández-Rozas I, Aguado MG, Becerra-Muñoz VM, Huang J, Pepe M, Cerrato E, Raposeiras S, Gonzalez A, Franco-Leon F, Wang L, Alfonso E, Ugo F, García-Prieto JF, Feltes G, Abumayyaleh M, Espejo-Paeres C, Jativa J, Masjuan AL, Macaya C, Carbonell Asíns JA, Estrada V; HOPE COVID-19 investigators. Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases. Arch Bronconeumol 2021;57 Suppl 2:13-20. [PMID: 33423874 DOI: 10.1016/j.arbres.2020.11.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
25 Tiew PY, Jaggi TK, Chan LLY, Chotirmall SH. The airway microbiome in COPD, bronchiectasis and bronchiectasis-COPD overlap. Clin Respir J 2021;15:123-33. [PMID: 33063421 DOI: 10.1111/crj.13294] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
26 Li N, Yang Z, Liao B, Pan T, Pu J, Hao B, Fu Z, Cao W, Zhou Y, He F, Li B, Ran P. Chronic exposure to ambient particulate matter induces gut microbial dysbiosis in a rat COPD model. Respir Res 2020;21:271. [PMID: 33076910 DOI: 10.1186/s12931-020-01529-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
27 Liu J, Ran Z, Wang F, Xin C, Xiong B, Song Z. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease. Crit Rev Microbiol 2021;47:1-12. [PMID: 33040638 DOI: 10.1080/1040841X.2020.1830748] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]